Contemporary OB/GYN week in review: maternal syphilis, abortion laws, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: maternal syphilis, abortion laws, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, February 12 - Friday, February 16, 2024), and click each link to read and watch anything you may have missed.
1.) CDC data reveals surge in maternal syphilis rates
The Centers for Disease Control and Prevention's latest report unveils a 222% rise in maternal syphilis cases per 100,000 live births from 2016 to 2022, with increases observed across racial, age, and perinatal care groups nationwide.
Click here for the full article.
2.) Impact of abortion laws on OBGYN residency applications
Recent research suggests strict abortion laws may deter applicants to obstetrics and gynecology residency programs, with implications for medical education and workforce diversity.
Click here for the full article.
3.) Ultrasound method enhances preterm birth risk assessment
A novel ultrasound technique allows for early and accurate prediction of preterm birth risk, potentially revolutionizing prenatal care for first-time pregnant women.
Click here for the full article.
4.) Cefepime–Taniborbactam outperforms meropenem in treating complicated UTI
A recent study demonstrated the superior efficacy of cefepime–taniborbactam over meropenem for managing complicated urinary tract infections, suggesting a promising treatment option amid rising antibiotic resistance challenges.
Click here for the full article.
5.) Safely evaluating penicillin allergy with 2-step Graded Oral Challenge
Recent findings revealed the efficacy and safety of the 2-step Graded Oral Challenge method in assessing penicillin allergy risk, offering a promising approach for improved patient care and antibiotic stewardship in low-risk individuals.
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
